UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Journal of allergy and clinical immunology, 2015-06, Vol.135 (6), p.1494-1501.e6

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacy of a Recombinant Grass Pollen Vaccine One Year after a 4 Month Treatment Course

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB407-AB407

Zieglmayer, Petra U.

2018

Link zum Volltext

Verfügbarkeit prüfen

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Journal of allergy and clinical immunology, 2009-09, Vol.124 (3), p.471-477.e1

2009

Link zum Volltext

Verfügbarkeit prüfen

Allergenexposition - Diagnostik - Immuntherapie: alles ganz einfach, oder?

Allergo Journal, 2023-05, Vol.32 (3), p.53-56

Zieglmayer, Petra

2023

Link zum Volltext

Verfügbarkeit prüfen

Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial

International journal of general medicine, 2024-02, Vol.17, p.419-428

2024

Link zum Volltext

Verfügbarkeit prüfen

IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational

Frontiers in immunology, 2021-06, Vol.12, p.687294-687294

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis

Journal of allergy and clinical immunology, 2016-06, Vol.137 (6), p.1733-1741

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen

PloS one, 2016-08, Vol.11 (8), p.e0160641-e0160641

2016

Link zum Volltext

Verfügbarkeit prüfen

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis

Scientific reports, 2017-05, Vol.7 (1), p.2555-7, Article 2555

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus : A Possible Biomarker for Allergic Asthma

Allergy, 2021, Asthma & Immunology Research, 13(1), , pp.154-163

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

Annals of allergy, asthma, & immunology, 2016-12, Vol.117 (6), p.690-696.e1

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study

The World Allergy Organization journal, 2018-10, Vol.11 (1), p.21-21, Article 21

2018

Link zum Volltext

Verfügbarkeit prüfen

AIT: Auf dem Weg zu optimierter Wirksamkeit und Verträglichkeit

hautnah dermatologie, 2019-03, Vol.35 (2), p.32-36

Zieglmayer, Petra

2019

Link zum Volltext

Verfügbarkeit prüfen

AIT: Auf dem Weg zu optimierter Wirksamkeit und Verträglichkeit

Hno-Nachrichten, 2019-02, Vol.49 (1), p.18-21

Zieglmayer, Petra

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma

The World Allergy Organization journal, 2020-08, Vol.13 (8), p.100261, Article 100261

2020

Link zum Volltext

Verfügbarkeit prüfen

A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber

Annals of allergy, asthma, & immunology, 2009-02, Vol.102 (2), p.116-120

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB62-AB62

2016

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Characterization of the Major Allergen Amb a 11 from Short Ragweed Pollen

The Journal of biological chemistry, 2016-06, Vol.291 (25), p.13076-13087

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure

PloS one, 2015-02, Vol.10 (2), p.e0114991

2015

Link zum Volltext

Verfügbarkeit prüfen

A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis

Clinical and Translational Allergy, 2021-06, Vol.11 (4), p.e12037-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose-Finding Efficacy and Safety Trial of House Dust Mite Sublingual Immunotherapy Tablet, MK-8237, Using an Environmental Exposure Chamber

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB403-AB403

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

EBioMedicine, 2016-09, Vol.11 (C), p.58-67

2016

Link zum Volltext

Verfügbarkeit prüfen

Food intolerances—a diagnostic challenge

Allergo journal international, 2022-03, Vol.31 (2), p.23-35

2022

Link zum Volltext

Verfügbarkeit prüfen

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration

British journal of clinical pharmacology, 2005-07, Vol.60 (1), p.24-31

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting

Allergo journal international, 2021-02, Vol.30 (1), p.46-49

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(69)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(41)
Immunology
(32)
Allergy
(28)
Humans
(27)
Allergies
(22)
Allergens
(19)
Female
(19)
Male
(19)
Adult
(17)
Immunotherapy
(17)
Asthma
(16)
Animals
(13)
Allergic Rhinitis
(12)
Middle Aged
(12)
Adolescent
(10)
Allergens - Immunology
(10)
Double-Blind Method
(10)
Allergy And Immunology
(9)
Rhinitis, Allergic, Seasonal - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Clinical Efficacy of a Recombinant Grass Pollen Vaccine One Year after a 4 Month Treatment Course

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Allergenexposition - Diagnostik - Immuntherapie: alles ganz einfach, oder?

Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial

IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational

Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis

Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus : A Possible Biomarker for Allergic Asthma

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study

AIT: Auf dem Weg zu optimierter Wirksamkeit und Verträglichkeit

AIT: Auf dem Weg zu optimierter Wirksamkeit und Verträglichkeit

Therapeutic equivalence and early onset of action of a novel water-soluble budesonide nasal spray (Budesolv 10) compared to Rhinocort® aqua 64 in patients suffering from grass pollen induced allergic rhinitis with or without asthma

A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber

Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period

Structural and Functional Characterization of the Major Allergen Amb a 11 from Short Ragweed Pollen

Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure

A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis

Dose-Finding Efficacy and Safety Trial of House Dust Mite Sublingual Immunotherapy Tablet, MK-8237, Using an Environmental Exposure Chamber

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

Food intolerances—a diagnostic challenge

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration

Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting

Suchergebnisse filtern